Quantcast

Latest Metformin Stories

2013-12-17 11:18:57

Treatment with the diabetes drug metformin appears to be associated with a modest reduction in body mass index (BMI) in obese children when combined with lifestyle interventions such as diet and exercise, according to a study by Marian S. McDonagh, Pharm. D., of the Oregon Health & Science University, and colleagues. Childhood obesity is a health problem in the United States, with nearly 17 percent of children being obese. Metformin is approved by the Food and Drug Administration to...

diabetes med affects men's and women's hearts differently
2013-12-12 15:24:01

Brett Smith for redOrbit.com - Your Universe Online In a new study from researchers at at Washington University School of Medicine, the type 2 diabetes drug metformin was found to have different effects on the hearts of men and women, despite managing blood sugar the same in both sexes. According to the study, which was published in the December issue of the American Journal of Physiology - Heart and Circulatory Physiology, the drug had positive effects on women’s heart health, but...

2013-12-10 23:19:52

Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022. London (PRWEB) December 10, 2013 PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being...

2013-12-10 23:19:45

Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - India Drug Forecast and Market Analysis to 2022. London (PRWEB) December 10, 2013 PharmaPoint: Type 2 Diabetes - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - India Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked...

2013-12-10 23:19:39

Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - China Drug Forecast and Market Analysis to 2022. London (PRWEB) December 10, 2013 PharmaPoint: Type 2 Diabetes - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - China Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked...

2013-12-10 23:04:32

Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - US Drug Forecast and Market Analysis to 2022. London (PRWEB) December 10, 2013 PharmaPoint: Type 2 Diabetes - US Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - US Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a...

2013-12-05 23:48:03

No data on patients with metformin intolerance or contraindication The drug saxagliptin (trade name: Onglyza) has been approved also as monotherapy in Germany since July 2013 for certain adults with type 2 diabetes mellitus. It is an option when drug treatment is needed, but the drug metformin is not tolerated or cannot be used. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.